Best Traditional Pharmaceuticals Companies in Canada
The 63 best Traditional Pharmaceuticals companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: HLS Therapeutics.
- HTF Market Intelligence
- Coherent Market Insights
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in Canada
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sterinova Manufacturer of shell molding castings in non-ferrous metals | $70M | — | 100 | 2012 | Jean-Philippe Gentes President & CEO | — | — | 1 partnership · 1 award |
| 2 | Uman Pharma Provider of steelwork, cladding, and refurbishment services for industrial, agricultural, and commercial… | $26M | — | 72 | 2008 | Luc Vaugeois CEO & Director | — | — | — |
| 3 | Alveda Pharmaceuticals Manufacturer if generic drugs and medical devices | — | — | 10 | 2006 | — | — | — | — |
| 4 | Ambicare Provider of high-quality, affordable generic pharmaceutical products | — | — | — | 2018 | Madhu Venkat CEO | — | — | — |
| 5 | Anusol Manufacturer of pain relief drugs | — | — | — | 2000 | Gregory Drohan CEO | — | — | — |
| 6 | Apotex Provider of generics, innovative branded pharmaceuticals, biosimilars, and consumer health products | — | — | 201 | 1974 | Jeff Watson CEO & President | 14 signals ▲367% IPO · M&A · Leadership | 417 patents Pharmaceutical solid forms, salts, and crystalline polymorphs of active drug compounds | — |
| 7 | Canadian National Pharma Group Manufacturer of generic drugs | — | — | — | 2014 | Marcus Dahl CEO | — | — | — |
| 8 | capcium A privately-owned Montreal-based global leader in softgel manufacturing. | — | — | 59 | 2013 | Sylvain Duvernay Co-Founder & CEO | — | 6 patents Lipid nanoparticle formulations for targeted drug and vaccine delivery | — |
Top 12 Traditional Pharmaceuticals companies in Canada
#1
Public · Vancouver, British Columbia · founded 2023$443.7Kraised▾
Manufacturer of drugs
- Mar 2024Post IPO$368.3K
- Jul 2023Post IPO$75.4K
#2
Public · Toronto, Ontario · founded 2015 · 96 employees$350Mraised▾
HLS Therapeutics is focused on acquiring and distributing commercial stage mature, or legacy, branded pharmaceutical drugs for the North American markets. It is focused on treatment products for the central nervous system (CNS).
- Jun 2019Post IPO$37.2M
- Aug 2015Post IPO$200M
- Jul 2015Post IPO$112.8M
- 2015Post IPO—
#3
Public · Vancouver, British Columbia · founded 2018$50Kraised▾
Developer of pharmaceutical products
- Mar 2024Seed$50K
#4
Public · Westmount, Quebec · founded 2014 · 831 employees$244.1Mraised▾
Acquires, licenses, and commercializes prescription pharmaceuticals. This company focuses on specialty pharmaceuticals for specific markets. The business model involves securing rights to innovative drugs and then managing their marketing and distribution. It operates across multiple countries, handling all aspects of bringing these medications to patients. The company's expertise lies in navigating the regulatory and commercial landscapes of the pharmaceutical industry to successfully launch and support these products.
- Feb 2019Conventional Debt$5M
- Feb 2017Post IPO$76.1M
- Apr 2014Post IPO$163M
#5
Acquired · Vancouver, British Columbia · founded 1986 · 133 employees$130Mraised▾
Correvio manufactures generic solid and liquid dosage forms such as tablets, capsules, liquid orals, and parenteral. The products are of various therapeutic categories including cardiovascular (BRINAVESS, AGGRASTAT), bacterial skin and skin structure infections, Pulmonary Arterial Hypertension, and others.
- Mar 2019Conventional Debt$10M
- May 2017Conventional Debt$50M
- May 2017Conventional Debt$30M
- May 2016Series B$13M
#6
Seed · St. John's, Newfoundland And Labrador · founded 2017 · 11 employees$353.9Kraised▾
{}
- Sep 2023Seed$353.9K
#7
Public · Winnipeg, Manitoba · founded 1997$47.7Mraised▾
Developer of affordable therapeutics and provider of e-commerce pharmacy services. This company focuses on the development and commercialization of innovative and affordable medications. It also operates an online pharmacy platform offering prescription medication delivery. The company's products are marketed to healthcare professionals and directly to consumers through its e-commerce channel. The online pharmacy fulfills prescriptions for a wide range of medications.
- Nov 2016Conventional Debt$44.6M
- Jun 2015Post IPO$3M
- Apr 2005Post IPO—
#8
Acquired · Calgary, Alberta · founded 2020 · 4 employees$8.1Mraised▾
Develops medicinal and licit consumer goods products
- Dec 2020Series A$8.1M
- Jul 2020Seed—
#9
Late Stage · Saint Hyacinthe, Quebec · founded 2012 · 100 employees$70Mraised▾
Manufacturer of shell molding castings in non-ferrous metals. It specializes in producing small casting parts for various industries, including automotive, marine, and construction. The company utilizes advanced manufacturing techniques to ensure cost-effective production while maintaining premium quality standards. Its offerings encompass a wide array of components such as connectors, grounding parts, and clamps. The manufacturing process emphasizes quality control and adherence to customer specifications. The company holds ISO 9001:2008 certification.
#10
Acquired · Candiac, Quebec · founded 2008 · 72 employees$26.4Mraised▾
Provider of steelwork, cladding, and refurbishment services for industrial, agricultural, and commercial sectors. They offer services encompassing individual elements or complete packages. The company focuses on delivering promised work on time and at competitive prices, relying on repeat business and referrals to build lasting client relationships. Their services are tailored to meet the specific needs of diverse clients within these sectors.
#11
Funding Raised · Montreal, Montreal · founded 1983 · 8 employees$7.9Mraised▾
Manufacturer of generic, branded, and over-the-counter pharmaceuticals. It serves both domestic and international markets. The company produces nearly 300 molecules in its facilities, adhering to stringent regulatory standards. It offers support services to healthcare professionals, including resources and patient care programs. A specialized division provides unique specialty medications. Significant investment is dedicated to research and development.
- Oct 2006Conventional Debt$1.5M
- May 2006Post IPO$3.9M
- Mar 2006Post IPO$500K
- Jan 2006Post IPO$500K
#12
Deadpooled · Halifax, Nova Scotia · founded 2001 · 11 employees$3.3Mraised▾
Origin BioMed manufactures over-the-counter consumer health products at therapeutic levels. Its product Neuragen is a non-prescriptive topically applied homeopathic drug used to relieve nerve pain caused by various conditions, including diabetic nerve pain, post-shingles pain, and chronic nerve pain. Other products include CanTea (Polyphenon catechins). Its products are available in pharmacies in Canada and the United States, as well as online.
- May 2009Series A$3.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in Canada
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,145 Canada-affiliated papers.
- University of Toronto153
- Ministry of Education92
- University of British Columbia81
- McGill University74
- Institute of Cancer Research64
- Computational biology10→101
- Chemical space3→52
- Small molecule4→39
- In silico2→33
- Virtual screening4→34
- Computational biology15→78
- Virtual screening1→36
- Docking (animal)2→32
- Drug development3→33
- Small molecule3→27
- Computational biology13→30
- Drug development2→19
- Data science3→11
- In silico1→8
- Chemical space1→7
Where drug discovery is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing drug discovery patents in Canada
Canada drug discovery patent filing is cooling — 31,927 filings from 8,000 assignees (2016–2025), led by UNIV British Columbia, UNIV Health Network, Xenon Pharmaceuticals; annual filings 2885→2717.
- UNIV British Columbia2362
- UNIV Health Network1718
- Xenon Pharmaceuticals1443
- UNIV Alberta822
- NAT RES Council Canada754
- UNIV Montreal722
- Hospital For SICK Children676
- Merck Frosst Canada675
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.